156 related articles for article (PubMed ID: 29198894)
1. Design, synthesis and biological evaluation of novel indole-xanthendione hybrids as selective estrogen receptor modulators.
Singla R; Gupta KB; Upadhyay S; Dhiman M; Jaitak V
Bioorg Med Chem; 2018 Jan; 26(1):266-277. PubMed ID: 29198894
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of novel indole-benzimidazole hybrids targeting estrogen receptor alpha (ER-α).
Singla R; Gupta KB; Upadhyay S; Dhiman M; Jaitak V
Eur J Med Chem; 2018 Feb; 146():206-219. PubMed ID: 29407951
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, in silico and biological evaluation of new indole based oxadiazole derivatives targeting estrogen receptor alpha.
Kaur K; Verma H; Gangwar P; Jangid K; Dhiman M; Kumar V; Jaitak V
Bioorg Chem; 2024 Jun; 147():107341. PubMed ID: 38593531
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel indole based heterocycles as selective estrogen receptor modulator.
Singla R; Prakash K; Bihari Gupta K; Upadhyay S; Dhiman M; Jaitak V
Bioorg Chem; 2018 Sep; 79():72-88. PubMed ID: 29723744
[TBL] [Abstract][Full Text] [Related]
5. Novel estrogen receptor (ER) modulators containing various hydrophobic bent-core structures.
Ohta K; Ogawa T; Kaise A; Endo Y
Bioorg Med Chem; 2014 Jul; 22(13):3508-14. PubMed ID: 24837157
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, structure-activity relationships and antagonistic effects in human MCF-7 breast cancer cells of flexible estrogen receptor modulators.
Lloyd DG; Smith HM; O'Sullivan T; Zisterer DM; Meegan MJ
Med Chem; 2005 Jul; 1(4):335-53. PubMed ID: 16789891
[TBL] [Abstract][Full Text] [Related]
7. Development of the β-lactam type molecular scaffold for selective estrogen receptor α modulator action: synthesis and cytotoxic effects in MCF-7 breast cancer cells.
Carr M; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
J Enzyme Inhib Med Chem; 2016; 31(sup3):117-130. PubMed ID: 27476825
[TBL] [Abstract][Full Text] [Related]
8. Design and Synthesis of Some Novel Estrogen Receptor Modulators as Anti-Breast Cancer Agents: In Vitro & In Vivo Screening, Docking Analysis.
Dube PN; Mokale SN
Anticancer Agents Med Chem; 2016; 16(11):1461-1467. PubMed ID: 26863879
[TBL] [Abstract][Full Text] [Related]
9. Rational approaches of drug design for the development of selective estrogen receptor modulators (SERMs), implicated in breast cancer.
Makar S; Saha T; Swetha R; Gutti G; Kumar A; Singh SK
Bioorg Chem; 2020 Jan; 94():103380. PubMed ID: 31757413
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and anticancer/antiestrogenic activities of novel indole-benzimidazoles.
Karadayi FZ; Yaman M; Kisla MM; Keskus AG; Konu O; Ates-Alagoz Z
Bioorg Chem; 2020 Jul; 100():103929. PubMed ID: 32464404
[TBL] [Abstract][Full Text] [Related]
11. Construction of benzofuranone library via a metal-free, one-pot intermolecular condensation, and their application as efficient estrogen receptor β modulators.
Peng X; Hu Z; Zhang J; Ning W; Zhang S; Dong C; Shi X; Zhou HB
Chem Commun (Camb); 2019 Dec; 55(97):14570-14573. PubMed ID: 31660550
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Biological Evaluation and In Silico Studies of Certain Oxindole-Indole Conjugates as Anticancer CDK Inhibitors.
Al-Warhi T; El Kerdawy AM; Aljaeed N; Ismael OE; Ayyad RR; Eldehna WM; Abdel-Aziz HA; Al-Ansary GH
Molecules; 2020 Apr; 25(9):. PubMed ID: 32349307
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.
Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H
Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819
[TBL] [Abstract][Full Text] [Related]
14. Benzothiepin-derived molecular scaffolds for estrogen receptor modulators: synthesis and antagonistic effects in breast cancer cells.
Meegan MJ; Barrett I; Zimmermann J; Knox AJ; Zisterer DM; Lloyd DG
J Enzyme Inhib Med Chem; 2007 Oct; 22(5):655-66. PubMed ID: 18035834
[TBL] [Abstract][Full Text] [Related]
15. Estrogen Receptor α (ERα)-targeting Compounds and Derivatives: Recent Advances in Structural Modification and Bioactivity.
Guo WY; Zeng SM; Deora GS; Li QS; Ruan BF
Curr Top Med Chem; 2019; 19(15):1318-1337. PubMed ID: 31215379
[TBL] [Abstract][Full Text] [Related]
16. Structure-based drug design, synthesis, In vitro, and In vivo biological evaluation of indole-based biomimetic analogs targeting estrogen receptor-α inhibition.
Hendy MS; Ali AA; Ahmed L; Hossam R; Mostafa A; Elmazar MM; Naguib BH; Attia YM; Ahmed MS
Eur J Med Chem; 2019 Mar; 166():281-290. PubMed ID: 30731397
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, and
Choudhari RC; Kaur K; Das A; Jaitak V
Curr Comput Aided Drug Des; 2024; 20(5):640-652. PubMed ID: 37888813
[TBL] [Abstract][Full Text] [Related]
18. Screening Estrogen Receptor Modulators in a Paper-Based Breast Cancer Model.
Whitman NA; Lin ZW; DiProspero TJ; McIntosh JC; Lockett MR
Anal Chem; 2018 Oct; 90(20):11981-11988. PubMed ID: 30226366
[TBL] [Abstract][Full Text] [Related]
19. Characterization of molecular and structural determinants of selective estrogen receptor downregulators.
Fan M; Rickert EL; Chen L; Aftab SA; Nephew KP; Weatherman RV
Breast Cancer Res Treat; 2007 May; 103(1):37-44. PubMed ID: 17033922
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Characterization and Biological Evaluation of Indole-Pyrazole Amalgamated α-Cyano Substituted Chalcones.
Bhale PS; Shringare SN; Khade AB; Chavan HV
Anticancer Agents Med Chem; 2021 Oct; 21(16):2216-2223. PubMed ID: 33563183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
